Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson's disease

Brain Research

Volumn 1589, Issue , 2014, Pages 93-104

  Morroni, Fabiana ^a   Sita, Giulia ^a   Tarozzi, Andrea ^a   Cantelli Forti, Giorgio ^a   Hrelia, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

6 (methylsulfinyl)hexyl; 6 hydroxydopamine; isothiocyanate; Neuroprotection; Oxidative stress; Parkinson'sdisease

Indexed keywords

6 (METHYLSULFINYL)HEXYL ISOTHIOCYANATE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; ISOTHIOCYANIC ACID; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTATHIONE REDUCTASE; ISOTHIOCYANIC ACID DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; INTRASTRIATAL DRUG ADMINISTRATION; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; MALE; METABOLISM; MOTOR ACTIVITY; NEOSTRIATUM; OXIDATIVE STRESS; PATHOLOGY; ROTAROD TEST; ROTATION; SUBSTANTIA NIGRA;

ANIMALS; APOMORPHINE; APOPTOSIS; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOPAMINERGIC NEURONS; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; ISOTHIOCYANATES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE; ROTAROD PERFORMANCE TEST; ROTATION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 84910123251     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.09.033     Document Type: Article

References (73)

1. S. Ahmad, M.B. Khan, M.N. Hoda, K. Bhatia, R. Haque, I.S. Fazili, A. Jamal, J.S. Khan, and D.P. Katare Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence Neurochem. Res. 37 3 2012 516 526 10.1007/s11064-011-0638-4
2. M.T. Armentero, R. Fancellu, G. Nappi, P. Bramanti, and F. Blandini Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease Neurobiol. Dis. 22 1 2006 1 9
3. R. Barros Silva, N.A. Santos, N.M. Martins, D.A. Ferreira, F. Barbosa Jr, V.C. Oliveira Souza, A. Kinoshita, O. Baffa, E. Del-Bel, and A.C. Santos Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats Neuroscience 233 2013 86 94 10.1016/j.neuroscience.2012.12.041
4. R. Betarbet, T.B. Sherer, and J.T. Greenamyre Animal models of Parkinson's disease Bioessays 24 4 2002 308 318
5. A. Björklund, and O. Lindvall Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals Brain Res. 83 3 1975 531 537
6. F. Blandini, G. Levandis, E. Bazzini, G. Nappi, and M.T. Armentero Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model Eur. J. Neurosci. 25 2007 397 405 10.1111/j.1460-9568.2006.05285.x
7. F. Blandini, M.T. Armentero, and E. Martignoni The 6-hydroxydopamine model: news from the past Parkinsonism Relat. Disord. 14 Suppl. 2 2008 S124 S129 10.1016/j.parkreldis.2008.04.015
8. J. Bové, and C. Perier Neurotoxin-based models of Parkinson's disease Neuroscience 211 2012 51 76 10.1016/j.neuroscience.2011.10.057
9. T.N. Chase, J.D. Oh, and P.J. Blanchet Neostriatal mechanisms in Parkinson's disease Neurology 51 1998 S30 S35
10. A. Cheramy, V. Leviel, and J. Glowinski Dendritic release of dopamine in the substantia nigra Nature 289 5798 1981 537 542
11. S.J. Chinta, and J.K. Andersen Redox imbalance in Parkinson's disease Biochim. Biophys. Acta 1780 11 2008 1362 1367 10.1016/j.bbagen.2008.02.005
12. J.D. Clarke, R.H. Dashwood, and E. Ho Multi-targeted prevention of cancer by sulforaphane Cancer Lett. 269 2 2008 291 304 10.1016/j.canlet.2008.04.018
13. T.J. Collier, C.E. Sortwell, J.D. Elsworth, J.R. Taylor, R.H. Roth, J.R. Sladek Jr, and D.E. Redmond Jr Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease J. Comp. Neurol. 442 4 2002 320 330
14. S.J. Crocker, P.D. Smith, V. Jackson-Lewis, W.R. Lamba, S.P. Hayley, E. Grimm, S.M. Callaghan, R.S. Slack, E. Melloni, S. Przedborski, G.S. Robertson, H. Anisman, Z. Merali, and D.S. Park Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease J. Neurosci. 23 10 2003 4081 4091
15. A. Currais, and P. Maher Functional consequences of age-dependent changes in glutathione status in the brain Antioxid. Redox Signal. 19 8 2013 813 822 10.1089/ars.2012.4996
16. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 6 2003 889 909
17. J.J. Didonet, J.C. Cavalcante, S. Souza Lde, M.S. Costa, E. André, P. Soares-Rachetti Vde, R. Guerrini, G. Calo', and E.C. Gavioli Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice Behav. Brain Res. 266 29-36 2014 10.1016/j.bbr.2014.03.002
18. A.T. Dinkova-Kostova, and P. Talalay Direct and indirect antioxidant properties of inducers of cytoprotective proteins Mol. Nutr. Food Res. 52 Suppl. 1 2008 S128 S138 10.1002/mnfr.200700195
19. R. Dringen, and J. Hirrlinger Glutathione pathways in the brain Biol. Chem. 384 4 2003 505 516 10.1515/BC.2003.059
20. S.H. Fox, B. Moser, and J.M. Brotchie Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease Exp. Neurol. 151 1 1998 35 49
21. R. Franco, and J.A. Cidlowski Glutathione efflux and cell death Antioxid. Redox Signal. 17 12 2012 1694 1713 10.1089/ars.2012.4553
22. S. Gandhi, and A.Y. Abramov Mechanism of oxidative stress in neurodegeneration Oxid. Med. Cell. Longev. 2012 2012 428010 10.1155/2012/428010
23. A. Garcia-Garcia, L. Zavala-Flores, H. Rodriguez-Rocha, and R. Franco Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease Antioxid. Redox Signal. 17 12 2012 1764 1784 10.1089/ars.2011.4501
24. Y. Glinka, M. Gassen, and M.B. Youdim Mechanism of 6-hydroxydopamine neurotoxicity J. Neural Transm. Suppl. 50 1997 55 66
25. K. Hanrott, L. Gudmunsen, M.J. O'Neill, and S. Wonnacott 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta J. Biol. Chem. 281 9 2006 5373 5382 10.1074/jbc.M511560200
26. N. Hasegawa, Y. Matsumoto, A. Hoshino, and K. Iwashita Comparison of effects of Wasabia japonica and allyl isothiocyanate on the growth of four strains of vibrio parahaemolyticus in lean and fatty tuna meat suspensions Int. J. Food Microbiol. 49 1-2 1999 27 34
27. D. Hernandez-Baltazar, M.E. Mendoza-Garrido, and D. Martinez-Fong Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine PLoS One 8 8 2013 e70951 10.1371/journal.pone.0070951
28. D.X. Hou, M. Fukuda, M. Fujii, and Y. Fuke Induction of NADPH:quinone oxidoreductase in murine hepatoma cells by methylsulfinyl isothiocyanates: methyl chain length-activity study Int. J. Mol. Med. 6 4 2000 441 444 10.3892/ijmm.6.4.441
29. D.X. Hou, Y. Korenori, S. Tanigawa, T. Yamada-Kato, M. Nagai, X. He, and J. He Dynamics of Nrf2 and Keap1 in ARE-mediated NQO1 expression by wasabi 6-(methylsulfinyl)hexyl isothiocyanate J. Agric. Food Chem. 59 22 2011 11975 11982 10.1021/jf2032439
30. H.I. Im, W.S. Joo, E. Nam, E.S. Lee, Y.J. Hwang, and Y.S. Kim Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice J. Pharmacol. Sci. 98 2 2005 185 189
31. A. Jazwa, A.I. Rojo, N.G. Innamorato, M. Hesse, J. Fernández-Ruiz, and A. Cuadrado Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism Antioxid. Redox Signal. 14 12 2011 2347 2360 10.1089/ars.2010.3731
32. P. Jenner Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease Acta Neurol. Scand. Suppl. 146 1993 6 13
33. T. Kawasaki, K. Ishihara, Y. Ago, A. Baba, and T. Matsuda Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum J. Pharmacol. Exp. Ther. 322 1 2007 274 281
34. D. Kirik, C. Rosenblad, and A. Björklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp. Neurol. 152 2 1998 259-7
35. M.M. Khan, S.S. Raza, H. Javed, A. Ahmad, A. Khan, F. Islam, M.M. Safhi, and F. Islam Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease Neurotox. Res. 22 1 2012 1 15 10.1007/s12640-011-9295-2
36. S.R. Kopalli, S.J. Noh, S. Koppula, and Y.H. Suh Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease Neurotoxicology 34 2013 25 32 10.1016/j.neuro.2012.10.003
37. Y. Korenori, S. Tanigawa, T. Kumamoto, S. Qin, Y. Daikoku, K. Miyamori, M. Nagai, and D.X. Hou Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression Mol. Nutr. Food Res. 57 5 2013 854 864 10.1002/mnfr.201200689
38. K.P. Kuruvilla, M.S. Nandhu, J. Paul, and C.S. Paulose Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation J. Neurol. Sci. 331 1-2 2013 31 37 10.1016/j.jns.2013.04.020
39. S.C. Kumer, and K.E. Vrana Intricate regulation of tyrosine hydroxylase activity and gene expression J. Neurochem. 67 2 1996 443 462 10.1046/j.1471-4159.1996.67020443.x
40. R. Li, T. Liang, L. Xu, N. Zheng, K. Zhang, and X. Duan Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway Brain Res. 1523 2013 1 9 10.1016/j.brainres.2013.05.046
41. X. Liu, H. Zou, C. Slaughter, and X. Wang DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis Cell 89 2 1997 175 184
42. J. Lotharius, and P. Brundin Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein Nat. Rev. Neurosci. 3 12 2002 932 942 10.1038/nrn983
43. J. Lu, D.M. Wu, Y.L. Zheng, B. Hu, W. Cheng, and Z.F. Zhang Purple sweet potato color attenuates domoic acid-induced cognitive deficits by promoting estrogen receptor-α-mediated mitochondrial biogenesis signaling in mice Free Radic. Biol. Med. 52 3 2012 646 659 10.1016/j.jnutbio.2012.07.009
44. H.L. Martin, and P. Teismann Glutathione - a review on its role and significance in Parkinson's disease FASEB J. 23 10 2009 3263 3272 10.1096/fj.08-125443
45. M. Merad-Boudia, A. Nicole, D. Santiard-Baron, C. Saille, and I. Cebal-los-Picot Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease Biochem. Pharmacol. 56 1998 645 655
46. M. McCollum, Z. Ma, E. Cohen, R. Leon, R. Tao, J.Y. Wu, D. Maharaj, and J. Wei Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease Mol. Neurobiol. 41 2-3 2010 410 419 10.1007/s12035-010-8118-4
47. K. Mizuno, T. Kume, C. Muto, Y. Takada-Takatori, Y. Izumi, H. Sugimoto, and A. Akaike Glutathione biosynthesis via activation of the nuclear factor E2-related factor 2 (Nrf2) - antioxidant-response element (ARE) pathway is essential for neuroprotective effects of sulforaphane and 6-(methylsulfinyl) hexyl isothiocyanate J. Pharmacol. Sci. 115 3 2011 320 328 10.1254/jphs.10257FP
48. Y. Morimitsu, K. Hayashi, Y. Nakagawa, H. Fujii, F. Horio, K. Uchida, and T. Osawa Antiplatelet and anticancer isothiocyanates in Japanese domestic horseradish, Wasabi Mech. Ageing Dev. 116 2-3 2000 125 134
49. F. Morroni, A. Tarozzi, G. Sita, C. Bolondi, J.M. Zolezzi Moraga, G. Cantelli-Forti, and P. Hrelia Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease Neurotoxicology 36 2013 63 71 10.1016/j.neuro.2013.03.004
50. V.A. Movsesyan, A.G. Yakovlev, E.A. Dabaghyan, B.A. Stoica, and A.I. Faden Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway Biochem. Biophys. Res. Commun. 299 2002 201 207
51. M. Naziroglu, S. Kutluhan, I.S. Ovey, M. Aykur, and V.A. Yurekli Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum Nutr. Neurosci. 2013 (Epub ahead of print)
52. G. Paul, W. Meissner, S. Rein, D. Harnack, C. Winter, K. Hosmann, R. Morgenstern, and A. Kupsch Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease Exp. Neurol. 185 2 2004 272 280
53. G. Rozas, M.J. Guerra, and J.L. Labandeira-García An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism Brain Res. Brain Res. Protoc. 2 1 1997 75 84
54. H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415
55. A.H. Schapira, and P. Jenner Etiology and pathogenesis of Parkinson's disease Mov. Disord. 26 6 2011 1049 1055 10.1002/mds.23732
56. S. Sharma, S.K. Nemecz, S. Zhu, and V.E. Steele Identification of chemiopreventive agents by screening for identification of glutathione-S-transferase as a biomarker Methods Cell Sci. 19 1997 49 52
57. T. Shibata, H. Nakahara, N. Kita, Y. Matsubara, C. Han, Y. Morimitsu, N. Iwamoto, Y. Kumagai, M. Nishida, H. Kurose, N. Aoki, M. Ojika, and K. Uchida A food-derived synergist of NGF signaling: identification of protein tyrosine phosphatase 1B as a key regulator of NGF receptor-initiated signal transduction J. Neurochem. 107 5 2008 1248 1260 10.1111/j.1471-4159.2008.05686.x
58. M. Smeyne, and R.J. Smeyne Glutathione metabolism and Parkinson's disease Free Radic. Biol. Med. 62 2013 13 25 10.1016/j.freeradbiomed.2013.05.001
59. A. Tarozzi, F. Morroni, A. Merlicco, S. Hrelia, C. Angeloni, G. Cantelli-Forti, and P. Hrelia Sulforaphane a san inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line J. Neurochem. 111 5 2009 1161 1171 10.1111/j.1471-4159.2009.06394.x
60. A. Tarozzi, A. Merlicco, F. Morroni, C. Bolondi, P. Di Iorio, R. Ciccarelli, S. Romano, P. Giuliani, and P. Hrelia Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by amyloid-beta peptide oligomers J. Biol. Regul. Homeost. Agents 24 3 2010 297 306
61. A. Tarozzi, F. Morroni, C. Bolondi, G. Sita, P. Hrelia, A. Djemil, and G. Cantelli-Forti Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line Int. J. Mol. Sci. 13 9 2012 10899 10910 10.3390/ijms130910899
62. A. Tarozzi, C. Angeloni, M. Malaguti, F. Morroni, S. Hrelia, and P. Hrelia Sulforaphane as a potential protective phytochemical against neurodegenerative diseases Oxid. Med. Cell. Longev. 2013 2013 415078 10.1155/2013/415078
63. W.G. Tatton, R. Chalmers-Redman, D. Brown, and N. Tatton Apoptosis in Parkinson's disease: signals for neuronal degradation Ann. Neurol. 53 2003 S61 S70 10.1002/ana.10489
64. A.H. Tsang, and K.K. Chung Oxidative and nitrosative stress in Parkinson's disease Biochim. Biophys. Acta 1792 7 2009 643 650 10.1016/j.bbadis.2008.12.006
65. T. Uto, M. Fujii, and D.X. Hou Inhibition of lipopolysaccharide-induced cyclooxygenase-2 transcription by 6-(methylsulfinyl) hexyl isothiocyanate, a chemopreventive compound from Wasabia japonica (Miq.) Matsumura, in mouse macrophages Biochem. Pharmacol. 70 12 2005 1772 1784
66. M. Watanabe, M. Ohata, S. Hayakawa, M. Isemura, S. Kumazawa, T. Nakayama, M. Furugori, and N. Kinae Identification of 6-methylsulfinylhexyl isothiocyanate as an apoptosis-inducing component in wasabi Phytochemistry 62 5 2003 733 739
67. I.Q. Whishaw, K. Li, P.A. Whishaw, B. Gorny, and G.A. Metz Distinct forelimb and hind limb stepping impairments in unilateral dopamine-depleted rats: use of the rotorod as a method for the qualitative analysis of skilled walking J. Neurosci. Methods 126 1 2003 13 23
68. J. Xiang, G.N. Alesi, N. Zhou, and R.F. Keep Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress Am. J. Physiol. Regul. Integr. Comp. Physiol. 303 1 2012 R1 R7 10.1152/ajpregu.00518.2011
69. J. Yoshida, S. Nomura, N. Nishizawa, Y. Ito, and K. Kimura Glycogen synthase kinase-3β inhibition of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum) Biosci. Biotechnol. Biochem. 75 1 2011 136 139
70. G.D. Zeevalk, R. Razmpour, and L.P. Bernard Glutathione and Parkinson's disease: is this the elephant in the room Biomed. Pharmacother. 62 2008 236 249 10.1016/j.biopha.2008.01.017
71. Y. Zhang Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates Carcinogenesis 22 2001 425 431
72. Y. Zhao, and B. Zhao Oxidative stress and the pathogenesis of Alzheimer's disease Oxid. Med. Cell. Longev. 2013 2013 316523 10.1155/2013/316523
73. C.L. Zuch, V.K. Nordstroem, L.A. Briedrick, G.R. Hoernig, A.C. Granholm, and P.C. Bickford Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion J. Comp. Neurol. 427 3 2000 440 454 10.1002/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7